SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-042607
Filing Date
2021-08-09
Accepted
2021-08-09 16:03:07
Documents
61
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vor-10q_20210630.htm   iXBRL 10-Q 2780512
2 EX-31.1 vor-ex311_6.htm EX-31.1 19190
3 EX-31.2 vor-ex312_7.htm EX-31.2 19194
4 EX-32.1 vor-ex321_8.htm EX-32.1 17164
  Complete submission text file 0001564590-21-042607.txt   7376250

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vor-20210630.xsd EX-101.SCH 39850
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vor-20210630_cal.xml EX-101.CAL 38309
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vor-20210630_def.xml EX-101.DEF 128071
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vor-20210630_lab.xml EX-101.LAB 313132
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vor-20210630_pre.xml EX-101.PRE 237025
10 EXTRACTED XBRL INSTANCE DOCUMENT vor-10q_20210630_htm.xml XML 1153517
Mailing Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39979 | Film No.: 211156388
SIC: 2836 Biological Products, (No Diagnostic Substances)